Ab&B Biotech
Ab&B Biotech, officially known as Ab&B Biotechnology Co., Ltd., is a leading player in the biotechnology industry, headquartered in China (CN). Founded in 2010, the company has established a strong presence in major operational regions across Asia and beyond, focusing on innovative solutions in biopharmaceuticals and agricultural biotechnology. Specialising in the development of cutting-edge bioproducts, Ab&B Biotech offers unique services that include enzyme production and microbial fermentation. Their commitment to research and development has positioned them as a key contributor to advancements in sustainable agriculture and health sciences. With a reputation for quality and innovation, Ab&B Biotech continues to achieve significant milestones, solidifying its market position as a trusted partner in the biotech sector.
DitchCarbon Score
How does Ab&B Biotech's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ab&B Biotech's score of 27 is higher than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Ab&B Biotech's reported carbon emissions
In 2023, Ab&B Biotech reported total carbon emissions of approximately 9,063,000 kg CO2e, comprising about 1,242,000 kg CO2e from Scope 1 and about 8,403,000 kg CO2e from Scope 2 emissions. The following year, 2024, emissions decreased significantly, with Scope 1 emissions dropping to about 94,000 kg CO2e and Scope 2 emissions rising to approximately 11,548,000 kg CO2e, resulting in total emissions of around 11,642,000 kg CO2e. Despite these figures, Ab&B Biotech has not disclosed any specific reduction targets or initiatives as part of their climate commitments. The absence of documented reduction strategies suggests a need for further transparency regarding their long-term climate goals and actions. The company operates within a sector that increasingly prioritises sustainability, making it essential for them to establish clear commitments to reduce their carbon footprint in the future.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2023 | 2024 | |
|---|---|---|
| Scope 1 | 1,242,000 | 00,000 |
| Scope 2 | 8,403,000 | 00,000,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ab&B Biotech is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
